Press release from Companies
Publicerat: 2021-06-24 11:21:55
Eevia Health Plc has received the following notification pursuant to Article 19 of the Market Abuse Regulation: ____________________________________________ Person subject to the notification requirement Name: Nurmi-Aro, Kim Position: Chief Financial Officer Issuer: Eevia Health Plc LEI: 743700NO7D0UA8J1MQ31 Notification type: INITIAL NOTIFICATION Reference number: 743700NO7D0UA8J1MQ31_20210621133215_4 ____________________________________________ Transaction date: 2021-06-17 Venue: SPOTLIGHT (XSAT) Instrument type: SHARE ISIN: FI4000496658 Nature of the transaction: SUBSCRIPTION Transaction details (1): Volume: 13,200 Unit price: 0.745 EUR Aggregated transactions (1): Volume: 13,200 Volume weighted average price: 0.745 EUR For more information, please contact: Tel.: +358 504 44 0717 About Eevia Eevia Health Plc, founded in March 2017, is a small, but fast-growing Finnish manufacturer of 100% organically certified plant extracts. The Company addresses significant health problems with bioactive compounds extracted from plant material from the pristine Finnish forests near the Arctic Circle. The extracts, which have scientifically documented health benefits, are sold B2B as ingredients to dietary supplements and food brands globally. To learn more, please visit www.eeviahealth.com or follow Eevia Health on LinkedIn @EeviaHealth.
Kim Nurmi-Aro, CFO